Determination of factor X and heparin with chromogenic substrate
Aiach, M.; Michaud, A.; Capron, L.; Fiessinger, J.N.
Acta Chirurgica Scandinavica. Supplementum 509: 109-113
1982
ISSN/ISBN: 0301-1860 PMID: 6962612 Document Number: 183633
Document emailed within 1 workday
Related Documents
Nakamura, S.; Takizawa, N.; Nakanishi, K.; Igarashi, M. 1980: On the determination of plasma prekallikrein with chromogenic peptide substrate Rinsho Byori. Japanese Journal of Clinical Pathology 28(7): 670-674Lanevschi, A.; Kramer, J.W.; Greene, S.A.; Meyers, K.M. 1996: Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs American Journal of Veterinary Research 57(8): 1124-1130
Lee, C.; Barrowcliffe, T.; Bray, G.; Gomperts, E.; Hubbard, A.; Kemball-Cook, G.; Lilley, P.; Owens, D.; Von Tilberg, L.; Pasi, J. 1996: Pharmacokinetic in vivo comparison using 1-stage and chromogenic substrate assays with two formulations of Hemofil-M Thrombosis and Haemostasis 76(6): 950-956
Noto, A.; Ogawa, Y.; Mori, S.; Yoshioka, M.; Kitakaze, T.; Hori, T.; Nakamura, M.; Miyake, T. 1983: Simple, rapid spectrophotometry of urinary N-acetyl-beta-D-glucosaminidase, with use of a new chromogenic substrate Clinical Chemistry 29(10): 1713-1716
Van Voorthuizen, H.; Kluft, C. 1984: Improved assay conditions for automated antithrombin IIi determinations with the chromogenic substrate S-2238 Thrombosis and Haemostasis 52(3): 350-353
Tanaka, O.; Hayashi, S.; Hayashi, S.; Meguro, T.; Yamada, K. 1989: Fundamental examination of measurement of urinary urokinase inhibitor activity using chromogenic substrate Rinsho Byori. Japanese Journal of Clinical Pathology 37(6): 687-691
Sandset, P.M.; Larsen, M.L.; Abildgaard, U.; Lindahl, A.K.; Odegaard, O.R. 1991: Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 2(3): 425-433
Witt, I.; Tritschler, W. 1982: Alpha 1-antitrypsin: reference values in serum and plasma with benzoyl-D,L-arginine-p-nitroanilide, a chromogenic substrate Journal of Clinical Chemistry and Clinical Biochemistry 20(8): 587-591
Kutuzov, V.A.; Mikhaĭlov, V.V.; Kruglova, S.E.; Kutuzov, V.V.; Kirillov, A.P.; Krasnianskiĭ, V.P.; Pshenichnov, V.A.; Lebedinskaia, E.V. 1993: A comparative evaluation of an immunoenzyme analytical method using a fluorogenic or chromogenic substrate in determining the Marburg virus antigen Voprosy Virusologii 38(1): 17-18
Hopmeier, P.; Heuss, F.; Fischer, M. 1984: Changes in antithrombin III values during and after extracorporeal circulation in heart surgery, measured on the day of operation using a chromogenic substrate and a laser nephelometer Wiener Klinische Wochenschrift 96(24): 881-884
Martin, P.A.; Gaunnac, G.L.; Tsuji, K. 1986: Automation of microtiter plate-chromogenic substrate LAL endotoxin assay method by use of a modified Cetus Pro/Pette Express system Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 40(2): 61-66
Hiura, H.; Nishiyama, T.; Kimura, M.; Matoba, K.; Hayashi, O.; Sasaki, M.; Ishijima, C.; Irie, Y.; Yasuda, N. 1989: Recent progress on analysis of blood coagulation factors and fibrinolytic agents; new synthetic chromogenic substrate assays for hemostatic parameters Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 81: 214-219
Katagiri, H.; Itoh, S.; Uchida, T.; Kawai, Y.; Watanabe, K. 1999: Monitoring of plasma concentration of low molecular weight heparin--comparative evaluation with chromogenic and clotting assays Rinsho Byori. Japanese Journal of Clinical Pathology 47(11): 1046-1051
Kam, C.M.; Vlasuk, G.P.; Smith, D.E.; Arcuri, K.E.; Powers, J.C. 1990: Thioester chromogenic substrates for human factor VIIa: substituted isocoumarins are inhibitors of factor VIIa and in vitro anticoagulants Thrombosis and Haemostasis 64(1): 133-137
Lee, C.A.; Owens, D.; Bray, G.; Giangrande, P.; Collins, P.; Hay, C.; Gomperts, E.; Schroth, P.; Barrowcliffe, T. 1999: Pharmacokinetics of recombinant factor VIIi (recombinate) using one-stage clotting and chromogenic factor VIIi assay Thrombosis and Haemostasis 82(6): 1644-1647
Sampol, J.; Rossi, J.M.; Lejay, G. 1984: Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex Annales de Biologie Clinique 42(1): 21-23
Wen-yao Huang; Wan, X.; Zhang, S. 2009: A Novel Chromogenic Peptide for Prekallikrein/Kallikrein Determination Clinical Laboratory 55(3-4): 106-113
Wu, X.-x.; Chen, Y.; Tan, J.-p.; Liu, M.-l.; Zhang, J.-p. 2013: Modulation of low molecular weight heparin and heparin-binding epidermal growth factor on biological functions of human first trimester trophoblast Zhonghua Fu Chan Ke Za Zhi 48(2): 107-112
Bol'shakova, T.D.; Iakunin, G.A.; Smolianitskiĭ, A.Ia. 1985: Chromogenic substrates for determining coagulation factor X and their use in clinical practice (review of the literature) Laboratornoe Delo 1985(11): 643-648
Han, P.; Fung, K.P.; Rahdakrishnan, U. 1991: Lack of agreement of chromogenic and clotting assays for factor X and protein C in warfarinised plasma Thrombosis and Haemostasis 65(4): 360-363